Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cooper University Health Care operates as the leading academic health system in southern New Jersey and the Delaware Valley. It provides comprehensive inpatient and outpatient services including primary care, specialty care in over 75 areas such as oncology (in partnership with MD Anderson), trauma services as the region's only Level I Trauma Center in South Jersey—the busiest in the region—and advanced surgical and medical subspecialties. The organization also serves as a major teaching site through its affiliation with Cooper Medical School of Rowan University. It has been recognized for high performance by U.S. News & World Report and Forbes. No clinical trial pipeline or drug development results; instead offers access to clinical trials via MD Anderson partnership. Serves more than two million patients annually through its flagship hospital (~663 beds), Cape Regional facility (~213 beds), three urgent care centers, outpatient surgery center and over 100 ambulatory offices. Recent expansions include acquisition of Cape Regional Health System and opening new facilities such as Moorestown Mall campus. Revenue exceeds $2 billion annually.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cooper University Health Care.